VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Aldosterone and the Metabolic Syndrome

Phase 1

Completed

Conditions: Diabetes Mellitus
Metabolic Diseases
Glucose Metabolism Disorders
Endocrine System Diseases

Interventions: Drug: Hydrochlorothiazide (HCTZ)
Drug: Aliskiren 150 mg (ALI 150)
Drug: Spironolactone (SPL 25)
Drug: Spironolactone 50 mg (SPL 50)
Drug: Aliskiren 300 mg (ALI 300)

First Posted Date: 2010-04-14

Last Posted Date: 2018-11-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 69

Registration Number: NCT01103245

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Study of Effects of L-Arginine in Colitis and Colon Cancer

Completed

Conditions: Colon Cancer
Ulcerative Colitis

First Posted Date: 2010-03-24

Last Posted Date: 2017-03-31

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 204

Registration Number: NCT01091558

Locations: 🇺🇸
Vanderbilt Hospital, Nashville, Tennessee, United States

A Computerized Asthma Management System in the Pediatric Emergency Department

Not Applicable

Completed

Conditions: Asthma

Interventions: Other: Computerized Asthma Management System

First Posted Date: 2010-02-17

Last Posted Date: 2018-08-17

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1631

Registration Number: NCT01070147

Locations: 🇺🇸
Vanderbilt Children's Hospital, Nashville, Tennessee, United States

Anterior Cruciate Ligament (ACL) Reconstruction- Bioabsorbable Screw

Completed

Conditions: Rupture of Anterior Cruciate Ligament

First Posted Date: 2010-02-17

Last Posted Date: 2024-02-20

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 67

Registration Number: NCT01069588

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Identification of Inpatients at Risk for Poor Glycemic Control

Completed

Conditions: Hypoglycemia
Hyperglycemia

Interventions: Other: No interventions will be used in this study

First Posted Date: 2010-01-06

Last Posted Date: 2017-04-04

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 33011

Registration Number: NCT01043042

Locations: 🇺🇸
Vanderbilt University Hospital, Nashville, Tennessee, United States

Evaluation of the Gestational Diabetes Self-Management Education Program and Quality Improvement Plan

Withdrawn

Conditions: Gestational Diabetes

First Posted Date: 2009-12-11

Last Posted Date: 2017-12-08

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT01030744

Locations: 🇺🇸
Vanderbilt University : Vanderbilt Diabetes Center (VDC), Nashville, Tennessee, United States

Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery

Not Applicable

Terminated

Conditions: Prostatectomy
Nephrectomy
Robotics
Laparoscopy

Interventions: Device: Teleflex HemoLock clip
Device: Aesculap U-clip

First Posted Date: 2009-11-06

Last Posted Date: 2017-04-19

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 11

Registration Number: NCT01008709

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)

Not Applicable

Active, not recruiting

Conditions: Postural Tachycardia Syndrome

Interventions: Drug: Saline
Other: Placebo

First Posted Date: 2009-10-23

Last Posted Date: 2024-10-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 40

Registration Number: NCT01000350

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia

Completed

Conditions: Leukemia
Renal Toxicity

First Posted Date: 2009-10-12

Last Posted Date: 2017-04-10

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT00993135

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Pilot Trial of Statin Use in Burn Patients

Phase 2

Completed

Conditions: Burns

Interventions: Drug: Placebo
Drug: Rosuvastatin

First Posted Date: 2009-09-16

Last Posted Date: 2018-06-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 40

Registration Number: NCT00978419

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy